Literature DB >> 15217998

What is the most relevant standard of success in assisted reproduction? The next step to improving outcomes of IVF: consider the whole treatment.

E M E W Heijnen1, N S Macklon, B C J M Fauser.   

Abstract

Changing the way in which successful IVF treatment is defined offers a tool to improve efficacy while reducing costs and complications of treatment. Crucial to this paradigm shift is the move away from considering outcomes in terms of the single IVF cycle, and towards the started IVF treatment as a whole. We propose the most informative end-point of success in IVF to be the term singleton birth rate per started IVF treatment (or per given time period) in the overall context of patient discomfort, complications and costs. These end-points are important not only for patients, but also for clinicians, health economists and policy makers. Such an approach would encourage the development of patient-friendly and cheaper stimulation protocols with less stress, discomfort and side effects. The combination of mild ovarian stimulation with single embryo transfer may provide the same overall pregnancy rate per total IVF treatment, achieved in the same amount of time for similar direct costs, but with reduced patient stress and discomfort, and the near complete elimination of multiple pregnancies. This would offer major health and indirect cost benefits. If IVF success rates were to be expressed in terms of delivery of a term single baby per IVF treatment (or in a given treatment period), the introduction of single embryo transfer on a large scale would be facilitated.

Entities:  

Mesh:

Year:  2004        PMID: 15217998     DOI: 10.1093/humrep/deh368

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  15 in total

1.  Efficacy and safety of late-start Corifollitropin-alfa administration for controlled ovarian hyperstimulation in IVF: a cohort, case-control study.

Authors:  Alberto Revelli; Giulia Pittatore; Simona Casano; Stefano Canosa; Francesca Evangelista; Chiara Benedetto
Journal:  J Assist Reprod Genet       Date:  2015-01-15       Impact factor: 3.412

2.  The cumulative live birth rate of recombinant follicle-stimulating hormone alfa verse urinary human follicle-stimulating hormone for ovarian stimulation in assisted reproductive technology cycles.

Authors:  Chunxia Yang; Naijun Dong; Feng Li; Yurong Ji; Yu Pan; Hong She
Journal:  J Ovarian Res       Date:  2022-06-21       Impact factor: 5.506

3.  Success of frozen embryo transfer: Does the type of gonadotropin influence the outcome?

Authors:  Hesham Al-Inany; Pieter van Gelder
Journal:  Int J Womens Health       Date:  2010-08-09

4.  Acupuncture and in vitro fertilization: a retrospective chart review.

Authors:  Lee E Hullender Rubin; Michael S Opsahl; Lisa Taylor-Swanson; Deborah L Ackerman
Journal:  J Altern Complement Med       Date:  2013-01-30       Impact factor: 2.579

5.  Balancing selected medication costs with total number of daily injections: a preference analysis of GnRH-agonist and antagonist protocols by IVF patients.

Authors:  E Scott Sills; Gary S Collins; Shala A Salem; Christopher A Jones; Alison C Peck; Rifaat D Salem
Journal:  Reprod Biol Endocrinol       Date:  2012-08-30       Impact factor: 5.211

Review 6.  No common denominator: a review of outcome measures in IVF RCTs.

Authors:  Jack Wilkinson; Stephen A Roberts; Marian Showell; Daniel R Brison; Andy Vail
Journal:  Hum Reprod       Date:  2016-09-22       Impact factor: 6.918

Review 7.  Approaches to improve the diagnosis and management of infertility.

Authors:  P Devroey; B C J M Fauser; K Diedrich
Journal:  Hum Reprod Update       Date:  2009-04-20       Impact factor: 15.610

8.  A double-blind, non-inferiority RCT comparing corifollitropin alfa and recombinant FSH during the first seven days of ovarian stimulation using a GnRH antagonist protocol.

Authors:  P Devroey; R Boostanfar; N P Koper; B M J L Mannaerts; P C Ijzerman-Boon; B C J M Fauser
Journal:  Hum Reprod       Date:  2009-08-14       Impact factor: 6.918

9.  Preimplantation genetic diagnosis: design or too much design.

Authors:  W Verpoest
Journal:  Facts Views Vis Obgyn       Date:  2009

10.  Single center validation of routine blastocyst biopsy implementation.

Authors:  John B Whitney; Mitchel C Schiewe; Robert E Anderson
Journal:  J Assist Reprod Genet       Date:  2016-08-20       Impact factor: 3.412

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.